Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2018 07:00 ET | Source: Unum Therapeutics Inc.

Unum Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update

– Successfully Completed IPO and Concurrent Private Placement Raising $77 Million in Gross Proceeds – – Initiated Cohort Expansion of ATTCK-20-2 Phase I Trial of ACTR087 in Combination with Rituximab...
April 03, 2018 17:00 ET | Source: Unum Therapeutics Inc.

Unum Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with Seattle Genetics

CAMBRIDGE, Mass., April 03, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (“Unum Therapeutics”) (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of novel...
March 28, 2018 21:35 ET | Source: Unum Therapeutics Inc.

Unum Therapeutics Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX) (“Unum Therapeutics”), a clinical-stage biopharmaceutical company focused on the development of novel...